Advisors Asset Management’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.86M | Sell |
90,663
-137,670
| -60% | -$3.15M | 0.03% | 629 |
|
|
2026
Q1 | $5.03M | Sell |
228,333
-109,128
| -32% | -$1.9M | 0.08% | 328 |
|
|
2025
Q4 | $3.98M | Sell |
337,461
-123,460
| -27% | -$1.59M | 0.07% | 385 |
|
|
2025
Q3 | $7.3M | Sell |
460,921
-1,071
| -0.2% | -$15.5K | 0.12% | 205 |
|
|
2025
Q2 | $5.29M | Buy |
461,992
+71,897
| +18% | +$810K | 0.09% | 286 |
|
|
2025
Q1 | $5.28M | Buy |
390,095
+154,857
| +66% | +$2.57M | 0.1% | 264 |
|
|
2024
Q4 | $3.98M | Buy |
235,238
+139,836
| +147% | +$2.72M | 0.07% | 355 |
|
|
2024
Q3 | $1.94M | Buy |
+95,402
| New | +$1.95M | 0.04% | 566 |
|
|
2024
Q2 | – | Sell |
-4,300
| Closed | -$113K | – | 1444 |
|
|
2024
Q1 | $113K | Sell |
4,300
-35
| -0.8% | -$997 | ﹤0.01% | 1201 |
|
|
2023
Q4 | $137K | Sell |
4,335
-31
| -0.7% | -$841 | ﹤0.01% | 1166 |
|
|
2023
Q3 | $122K | Sell |
4,366
-27
| -0.6% | -$927 | ﹤0.01% | 1172 |
|
|
2023
Q2 | $162K | Sell |
4,393
-29
| -0.7% | -$885 | ﹤0.01% | 1152 |
|
|
2023
Q1 | $132K | Sell |
4,422
-70
| -2% | -$2.31K | ﹤0.01% | 1185 |
|
|
2022
Q4 | $138K | Buy |
4,492
+1,074
| +31% | +$32.2K | ﹤0.01% | 1190 |
|
|
2022
Q3 | $84K | Sell |
3,418
-5,293
| -61% | -$175K | ﹤0.01% | 1295 |
|
|
2022
Q2 | $279K | Sell |
8,711
-97,744
| -92% | -$3.6M | 0.01% | 1082 |
|
|
2022
Q1 | $3.35M | Sell |
106,455
-15,073
| -12% | -$471K | 0.05% | 410 |
|
|
2021
Q4 | $4.08M | Sell |
121,528
-23,465
| -16% | -$731K | 0.06% | 360 |
|
|
2021
Q3 | $4.21M | Sell |
144,993
-123,779
| -46% | -$4.01M | 0.06% | 316 |
|
|
2021
Q2 | $9.35M | Sell |
268,772
-141,213
| -34% | -$4.68M | 0.14% | 147 |
|
|
2021
Q1 | $11.4M | Sell |
409,985
-79,599
| -16% | -$2.12M | 0.18% | 112 |
|
|
2020
Q4 | $12.1M | Sell |
489,584
-172,522
| -26% | -$4.1M | 0.2% | 91 |
|
|
2020
Q3 | $13.8M | Buy |
662,106
+23,107
| +4% | +$446K | 0.26% | 66 |
|
|
2020
Q2 | $9.81M | Buy |
638,999
+134,138
| +27% | +$1.7M | 0.19% | 102 |
|
|
2020
Q1 | $4.48M | Buy |
504,861
+201,589
| +66% | +$2.91M | 0.11% | 191 |
|
|
2019
Q4 | $5.49M | Buy |
303,272
+165,775
| +121% | +$2.75M | 0.1% | 247 |
|
|
2019
Q3 | $2.05M | Buy |
137,497
+137,153
| +39,870% | +$2.23M | 0.04% | 526 |
|
|
2019
Q2 | $8.26K | Sell |
344
-5
| -1% | -$147 | ﹤0.01% | 1498 |
|
|
2019
Q1 | $13K | Hold |
349
| – | – | ﹤0.01% | 1497 |
|
|
2018
Q4 | $10K | Sell |
349
-12
| -3% | -$380 | ﹤0.01% | 1533 |
|
|
2018
Q3 | $14K | Sell |
361
-4
| -1% | -$175 | ﹤0.01% | 1528 |
|
|
2018
Q2 | $16K | Sell |
365
-4
| -1% | -$199 | ﹤0.01% | 1516 |
|
|
2018
Q1 | $18K | Sell |
369
-3
| -0.8% | -$150 | ﹤0.01% | 1443 |
|
|
2017
Q4 | $19K | Sell |
372
-9
| -2% | -$471 | ﹤0.01% | 1447 |
|
|
2017
Q3 | $19K | Sell |
381
-4
| -1% | -$189 | ﹤0.01% | 1447 |
|
|
2017
Q2 | $15K | Sell |
385
-602
| -61% | -$23.7K | ﹤0.01% | 1509 |
|
|
2017
Q1 | $38K | Sell |
987
-290
| -23% | -$8.73K | ﹤0.01% | 1462 |
|
|
2016
Q4 | $28K | Sell |
1,277
-475
| -27% | -$9.75K | ﹤0.01% | 1767 |
|
|
2016
Q3 | $28K | Sell |
1,752
-311
| -15% | -$3.55K | ﹤0.01% | 1759 |
|
|
2016
Q2 | $17K | Sell |
2,063
-1,766
| -46% | -$15.7K | ﹤0.01% | 1803 |
|
|
2016
Q1 | $27K | Sell |
3,829
-6,385
| -63% | -$32.1K | ﹤0.01% | 1711 |
|
|
2015
Q4 | $55K | Sell |
10,214
-2,032
| -17% | -$13K | ﹤0.01% | 1692 |
|
|
2015
Q3 | $79K | Buy |
+12,246
| New | +$128K | ﹤0.01% | 1583 |
|
Other funds holding CC
CCPM
Advisors Asset Management's CC Position: Q2 2026 in Review
Advisors Asset Management reduced its Chemours (CC) stake by 60% in Q2 2026, selling an estimated $3.15M and leaving 90,663 shares worth $1.86M. The position accounts for 0.03% of the portfolio, ranked #629.
Advisors Asset Management first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $13.8M in Q3 2020. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Advisors Asset Management held 90,663 shares of Chemours worth $1.86M as of Q2 2026.
- Advisors Asset Management sold 137,670 Chemours shares in Q2 2026, an estimated $3.15M.
- Chemours made up 0.03% of Advisors Asset Management's portfolio in Q2 2026, its #629 holding.
- Advisors Asset Management first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
- Advisors Asset Management's Chemours position peaked at $13.8M in Q3 2020.
- 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.